US drugstore chain Rite Aid has reported 1.8% increase in revenues from continuing operations for the third quarter of fiscal 2022.

The company’s revenues were $6.23bn compared to $6.12bn in the same period last year.

Rite Aid posted a net loss of $36.1m or $0.67 per share from continuing operations against net income of $4.3m or $0.08 per share last year.

The company said the increase in net loss was due to high facility exit and impairment charges.

Retail Pharmacy Segment revenues from continuing operations for the third quarter were up 7.9% and same store sales from continuing operations increased 4.4%.

Pharmacy Services Segment revenues were $1.9bn in the quarter.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Rite Aid president and chief executive officer Heyward Donigan said: “We delivered a solid quarter as we grew adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) by 12.7% versus last year.

“Despite challenges in the labour market, our pharmacists and store teams were able to meet the unprecedented volumes for Covid and flu immunisations, Covid testing and other clinical services, which clearly demonstrates our Lean work to free up capacity is paying off.”

For fiscal 2022, Rite Aid expects its total revenues to be in the range of $24.4bn and $24.7bn, and a net loss between $230m and $189m.

The drugstore chain revealed plans to close at least 63 stores as part of an ongoing business review.

The company, which operates more than 2,400 retail locations in the US, expects to find additional shops for closures in the next several months.

Donigan added: “Today, we also announced the first phase of a store closure programme to reduce costs, drive improved profitability and ensure that we have a healthy foundation to grow from, with the right stores in the right locations, for the communities we serve and for our business. We have identified an initial 63 stores for closure that is expected to provide an annual EBITDA benefit of approximately $25m.”